Options Data for US Stocks: End-of-Day and Historical Learn more

Try our APIs with free plan!

Faeth Therapeutics, Inc. Financial Data Overview

Price chart is built with Anychart

Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. The company was formerly known as Sensei Biotherapeutics, Inc. and changed its name to Faeth Therapeutics, Inc. in June 2026. The company was incorporated in 1999 and is headquartered in Rockville, Maryland.

Prev. Close 38.9403
Open 35.3318
High 39.8911
Low 34.9804
52 wk Range 7.45-42.143
Market Cap 933 M
Shares Outstanding 25 840 K
EPS -2.84
Beta -0.28

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Faeth Therapeutics, Inc. (top by weight)

Ticker
100-day Price Change
Weight
IWC.US iShares Micro-Cap ETF
-0.71 (-0.37%)
0.01

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Faeth Therapeutics, Inc. data using free add-ons & libraries


Get Faeth Therapeutics, Inc. Fundamental Data

Faeth Therapeutics, Inc. Fundamental data includes:

  • Net Revenue:
  • EBITDA: -36 640 000
  • Earnings Per Share: -56
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Faeth Therapeutics, Inc. Earnings data

Corporate Events Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2026-08-04
  • EPS/Forecast: -1.1
GET THE PACKAGE

Get Faeth Therapeutics, Inc. End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Faeth Therapeutics, Inc. News

Get Faeth Therapeutics, Inc. fresh news feed via Financial News API

Corporate Events Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Live chat support

Send the request

Leave your email and our team will contact you ASAP.